
Sanjay Singh, Partner – Deal Advisory, Head of Lifesciences, KPMG in India, identifies new generics opportunities, established manufacturing ecosystem, growing penetration of health insurance and talent pool as some of the key growth drivers for the Indian pharmaceutical industry over the next decade. IBT: The government is planning to come...









